BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29940462)

  • 1. 5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one derivatives as novel dual inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H and integrase.
    Sun L; Gao P; Dong G; Zhang X; Cheng X; Ding X; Wang X; Daelemans D; De Clercq E; Pannecouque C; Menéndez-Arias L; Zhan P; Liu X
    Eur J Med Chem; 2018 Jul; 155():714-724. PubMed ID: 29940462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of pyrrolyl diketo acid derivatives as dual inhibitors of HIV-1 integrase and reverse transcriptase ribonuclease H domain.
    Cuzzucoli Crucitti G; Métifiot M; Pescatori L; Messore A; Madia VN; Pupo G; Saccoliti F; Scipione L; Tortorella S; Esposito F; Corona A; Cadeddu M; Marchand C; Pommier Y; Tramontano E; Costi R; Di Santo R
    J Med Chem; 2015 Feb; 58(4):1915-28. PubMed ID: 25629256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity.
    Esposito F; Ambrosio FA; Maleddu R; Costa G; Rocca R; Maccioni E; Catalano R; Romeo I; Eleftheriou P; Karia DC; Tsirides P; Godvani N; Pandya H; Corona A; Alcaro S; Artese A; Geronikaki A; Tramontano E
    Eur J Med Chem; 2019 Nov; 182():111617. PubMed ID: 31442684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Docking and Molecular Dynamics Simulation Based Approach to Explore the Dual Inhibitor Against HIV-1 Reverse Transcriptase and Integrase.
    Chander S; Pandey RK; Penta A; Choudhary BS; Sharma M; Malik R; Prajapati VK; Murugesan S
    Comb Chem High Throughput Screen; 2017; 20(8):734-746. PubMed ID: 28641512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Hydroxypyrido[2,3-d]pyrimidin-2(1H)-ones as novel selective HIV integrase inhibitors obtained via privileged substructure-based compound libraries.
    Gao P; Zhang L; Sun L; Huang T; Tan J; Zhang J; Zhou Z; Zhao T; Menéndez-Arias L; Pannecouque C; Clercq E; Zhan P; Liu X
    Bioorg Med Chem; 2017 Oct; 25(20):5779-5789. PubMed ID: 28951095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the interaction between pyrrolyl diketoacids and HIV-1 integrase active site and comparison with RNase H.
    Corona A; di Leva FS; Rigogliuso G; Pescatori L; Madia VN; Subra F; Delelis O; Esposito F; Cadeddu M; Costi R; Cosconati S; Novellino E; di Santo R; Tramontano E
    Antiviral Res; 2016 Oct; 134():236-243. PubMed ID: 27659398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closely related antiretroviral agents as inhibitors of two HIV-1 enzymes, ribonuclease H and integrase: "killing two birds with one stone".
    Andréola ML
    Curr Pharm Des; 2004; 10(30):3713-23. PubMed ID: 15579066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach.
    Costi R; Métifiot M; Esposito F; Cuzzucoli Crucitti G; Pescatori L; Messore A; Scipione L; Tortorella S; Zinzula L; Novellino E; Pommier Y; Tramontano E; Marchand C; Di Santo R
    J Med Chem; 2013 Nov; 56(21):8588-98. PubMed ID: 24124919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors.
    Esposito F; Tramontano E
    Antivir Chem Chemother; 2014 Jan; 23(4):129-44. PubMed ID: 24150519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine.
    Wang Z; Vince R
    Bioorg Med Chem; 2008 Apr; 16(7):3587-95. PubMed ID: 18314335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 integrase and RNase H activities as therapeutic targets.
    Andréola ML; De Soultrait VR; Fournier M; Parissi V; Desjobert C; Litvak S
    Expert Opin Ther Targets; 2002 Aug; 6(4):433-46. PubMed ID: 12223059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the binding mode and resistance profile for a dual-target pyrrolyl diketo acid scaffold against HIV-1 integrase and reverse-transcriptase-associated ribonuclease H.
    Yang F; Zheng G; Fu T; Li X; Tu G; Li YH; Yao X; Xue W; Zhu F
    Phys Chem Chem Phys; 2018 Sep; 20(37):23873-23884. PubMed ID: 29947629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H.
    Marchand C; Beutler JA; Wamiru A; Budihas S; Möllmann U; Heinisch L; Mellors JW; Le Grice SF; Pommier Y
    Antimicrob Agents Chemother; 2008 Jan; 52(1):361-4. PubMed ID: 17967911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
    Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
    Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.
    Gu SX; Xue P; Ju XL; Zhu YY
    Bioorg Med Chem; 2016 Nov; 24(21):5007-5016. PubMed ID: 27658796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H.
    Kankanala J; Kirby KA; Huber AD; Casey MC; Wilson DJ; Sarafianos SG; Wang Z
    Eur J Med Chem; 2017 Dec; 141():149-161. PubMed ID: 29031062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.
    Xue P; Lu HH; Zhu YY; Ju XL; Pannecouque C; Zheng XJ; Liu GY; Zhang XL; Gu SX
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1640-1643. PubMed ID: 28314598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diketo acids derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.
    Di Santo R
    Curr Med Chem; 2011; 18(22):3335-42. PubMed ID: 21728968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors.
    Massari S; Corona A; Distinto S; Desantis J; Caredda A; Sabatini S; Manfroni G; Felicetti T; Cecchetti V; Pannecouque C; Maccioni E; Tramontano E; Tabarrini O
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):55-74. PubMed ID: 30362381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.